SciVision Biotech, Inc. engages in the research, development, and production of hyaluronic acid medical products. Its products include dermis & joint injection, skin care cream & masks and glucosamine tablets. The company was founded on November 12, 2001 and is headquartered in Kaohsiung, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company